Vicore Pharma Holding AB (publ) VCRE
Set alert
9.80 USD -0.40 -3.92%
At close · Oct 30
9.61 -0.19 -1.94%
After hours · Oct 30, 4:00 PM ET
9.74 Day range 9.97
8.66 52-week range 16.25
- YTD
- -39.69%
- 1 year
- -39.69%
- Open
- 9.74
- Prev close
- 10.20
- Mkt cap
- 276.01M
- Vol
- 11.89K
- Avg vol
- 21.31K
- EPS
- -2.04
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 9.74
- High
- 9.97
- Forward P/E
- 0.00
- Beta
- 0.12
- Short ratio
- 0.15
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 21, 2026
- 50-d avg
- 12.28
- 200-d avg
- 12.28
- 1y target
- 35.42
Financial health
FMP rating
C-1 / 5 overall
- DCF 3
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -68.1×
FY 2021 5y median -51.1× FY 2025
P/S 941×
FY 2021 5y median 0.0× FY 2025
P/B 3.3×
FY 2021 5y median 0.0× FY 2025
P/FCF -9.6×
FY 2021 5y median -6.3× FY 2025
EV/EBITDA -6.3×
FY 2021 5y median 0.0× FY 2025
EV/Sales 790×
FY 2021 5y median 0.0× FY 2025
FCF Yield -10.5%
FY 2021 5y median -15.8% FY 2025
Profitability
Gross Margin 100.0%
FY 2021 5y median 0.0% FY 2025
Operating Margin -11905.8%
FY 2021 5y median 0.0% FY 2025
Net Margin -12509.1%
FY 2021 5y median 0.0% FY 2025
ROE -43.6%
FY 2021 5y median 0.0% FY 2025
ROIC -41.3%
FY 2021 5y median 0.0% FY 2025
ROA -39.2%
FY 2021 5y median 0.0% FY 2025
Growth (YoY)
Revenue -96.5%
FY 2021 FY 2025
Operating Income -138.7%
FY 2021 FY 2025
EPS (diluted) -100.0%
FY 2021 FY 2025
Free Cash Flow -127.8%
FY 2021 FY 2025
Financial Health
Current Ratio 10.3×
FY 2021 5y median 0.0× FY 2025
Quick Ratio 10.3×
FY 2021 5y median 0.0× FY 2025
Debt / Equity 0.0×
FY 2021 5y median 0.0× FY 2025
Net Debt / EBITDA 1.2×
FY 2021 5y median 0.0× FY 2025
Interest Coverage -7574×
FY 2021 5y median -23795× FY 2025
Dividends
Dividend Yield 0.0%
FY 2021 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2021 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31